WA
BSTC

WFG Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

WFG Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$5K Hold
100
– – ﹤0.01% 1307
2017
Q1 		$5K Hold
100
– – ﹤0.01% 1235
2016
Q4 		$6K Buy
+100
New +$4.81K ﹤0.01% 1241

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

WFG Advisors's BSTC Position: Q2 2017 in Review

WFG Advisors held its BioSpecifics Technologies Corp. (BSTC) position steady in Q2 2017 at 100 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

WFG Advisors first reported a position in BSTC in Q4 2016 and has held it in 3 quarters since. The position peaked at $6K in Q4 2016. 90 funds tracked by Wall St. Rank hold BSTC as of Q2 2017.

  • WFG Advisors held 100 shares of BioSpecifics Technologies Corp. worth $5K as of Q2 2017.
  • WFG Advisors left its BioSpecifics Technologies Corp. share count unchanged in Q2 2017.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1307 holding.
  • WFG Advisors first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and has held it in 3 quarters since.
  • WFG Advisors's BioSpecifics Technologies Corp. position peaked at $6K in Q4 2016.
  • 90 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.